Fernández-Pérez, María-Piedad; Pérez-Navarro, Enrique; Alonso-Gordoa, Teresa; Conteduca, Vincenza; Font, Albert; Vázquez-Estevez, Sergio; González-del-Alba, Aranzazu; Wetterskog, Daniel; Antonarakis, Emmanuel-S; Mellado, Begoña; Fernández-Calvo, Ovidio; Méndez-Vidal, María
(WILEY, 2023-03)
BackgroundThere is a considerable need to incorporate biomarkers of resistance to new antiandrogen agents in the management of castration-resistant prostate cancer (CRPC). MethodsWe conducted a phase II trial of enzalutamide ...